Lidocain is one of 113 small molecule programs targeting Neuropathic Pain. It is currently in Preclinical.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
102 competitors in Migraine
Zonegran
Avicel
Effient
Magnesium
Aspirin /d
Flunarizine
Bayer Aspirin
Cervidil
Cymbalta
Adempas
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources